Cell and gene therapy share of medicine spending
Percentage of total medicine spending attributable to cell and gene therapies.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Every record
All records
1 record · 1 region · 2023
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios | IQVIA | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Cell and gene therapy share of medicine spending. Retrieved from https://statorigin.org/indicators/cell-and-gene-therapy-share-of-medicine-spending